Granulocyte-macrophage colony-stimulating factor therapy in patients with chemotherapy-induced aplasia and Clostridium difficile enterocolitis.
Geiger
R
R
Fussenegger
J
J
Allerberger
F
F
Maurer
K
K
Fink
F M
FM
D000293:Adolescent; D000741:Anemia, Aplastic / Q000150:complications / Q000209:etiology / Q000628:therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D002675:Child, Preschool; D004761:Enterocolitis, Pseudomembranous / Q000150:complications / Q000209:etiology / Q000628:therapy*; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor